Medtronic (MDT) Current Deferred Revenue (2025 - 2026)
Medtronic (MDT) reported Current Deferred Revenue of $249.0 million for Q2 2026, down 36.32% on a YoY basis from $391.0 million in Q2 2025, and down 12.01% sequentially from $283.0 million in Q1 2026.
Medtronic (MDT) Current Deferred Revenue (2025 - 2026) Analysis & Trends
Medtronic (MDT) has 2 years of Current Deferred Revenue data on file, last reported at $249.0 million in Q2 2026.
- For the quarter ending Q2 2026, Current Deferred Revenue fell 36.32% year-over-year to $249.0 million; the trailing twelve-month figure through Apr 2026 stood at $249.0 million (down 36.32% YoY), and the FY2026 full-year result was $249.0 million, down 36.32% from the prior year.
- Current Deferred Revenue eased to $249.0 million in Q2 2026, from $283.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $391.0 million in Q2 2025 to a low of $249.0 million in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 249.00 Mn |
| Jan 23, 2026 | 283.00 Mn |
| Oct 24, 2025 | 318.00 Mn |
| Jul 25, 2025 | 355.00 Mn |
| Apr 25, 2025 | 391.00 Mn |